First Time Loading...

Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932

Watchlist Manager
Wuhan Easy Diagnosis Biomedicine Co Ltd Logo
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Watchlist
Price: 20.79 CNY 1.81% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one Wuhan Easy Diagnosis Biomedicine Co Ltd stock under the Base Case scenario is 18.5 CNY. Compared to the current market price of 20.79 CNY, Wuhan Easy Diagnosis Biomedicine Co Ltd is Overvalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
18.5 CNY
Overvaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
58
vs Industry
61
Median 3Y
1.2
Median 5Y
1.4
Industry
2.4
Forward
1.1
More Details
9.2
P/E
P/E
Price to Earnings
9.2
vs History
31
vs Industry
42
Median 3Y
2.9
Median 5Y
3.7
Industry
23.2
Forward
1.5
More Details
2.1
P/OCF
P/OCF
Price to OCF
2.1
vs History
80
vs Industry
52
Median 3Y
2.7
Median 5Y
3.9
Industry
15.5
More Details
2.2
P/FCFE
P/FCFE
Price to FCFE
2.2
vs History
66
vs Industry
41
Median 3Y
3
Median 5Y
3
Industry
23.5
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
92
vs Industry
69
Median 3Y
1.2
Median 5Y
1.2
Industry
2.2
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
58
vs Industry
73
Median 3Y
0.8
Median 5Y
0.9
Industry
2.5
Forward
0.7
More Details
1.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.7
vs History
30
vs Industry
72
Median 3Y
1.2
Median 5Y
1.4
Industry
5.2
More Details
4.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.7
vs History
28
vs Industry
47
Median 3Y
1.5
Median 5Y
2
Industry
12.5
Forward
1.1
More Details
4.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
4.7
vs History
28
vs Industry
47
Median 3Y
1.5
Median 5Y
2
Industry
17.2
More Details
1.3
EV/OCF
EV/OCF
Enterprise Value to OCF
1.3
vs History
76
vs Industry
54
Median 3Y
1.6
Median 5Y
2.6
Industry
15.1
More Details
1.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1.4
vs History
57
vs Industry
44
Median 3Y
1.7
Median 5Y
1.6
Industry
19.7
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
90
vs Industry
74
Median 3Y
1.1
Median 5Y
1.1
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
Wuhan Easy Diagnosis Biomedicine Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
4.8B CNY 1.3 9.2 4.7 4.7
US
Abbott Laboratories
NYSE:ABT
183.5B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.1B USD 18.5 68 55.8 69.9
US
Stryker Corp
NYSE:SYK
124.8B USD 6 37.1 24.1 29.7
IE
Medtronic PLC
NYSE:MDT
108.5B USD 3.4 25.8 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.2B USD 7.2 60.2 30.7 45.3
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.5 55.6 18.6 39.3
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.6B USD 8.4 36.5 26.5 28.7
US
Dexcom Inc
NASDAQ:DXCM
50.9B USD 13.4 79.6 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.